Insights into the therapeutic potential of histone deacetylase inhibitor/immunotherapy combination regimens in solid tumors.
- DOI
- 10.1007/s12094-022-02779-x
- Published
- 2022 Jul
- Container
- Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12094-022-02779-x,
title = {Insights into the therapeutic potential of histone deacetylase inhibitor/immunotherapy combination regimens in solid tumors.},
author = {Sedky NK and Hamdan AA and Emad S and Allam AL and Ali M and Tolba MF},
year = {2022},
journal = {Clinical \& translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico},
doi = {10.1007/s12094-022-02779-x},
url = {https://doi.org/10.1007/s12094-022-02779-x}
}RIS
TY - JOUR TI - Insights into the therapeutic potential of histone deacetylase inhibitor/immunotherapy combination regimens in solid tumors. AU - Sedky NK AU - Hamdan AA AU - Emad S AU - Allam AL AU - Ali M AU - Tolba MF PY - 2022 JO - Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico DO - 10.1007/s12094-022-02779-x UR - https://doi.org/10.1007/s12094-022-02779-x ER -
APA
NK, S., AA, H., S, E., AL, A., M, A., & MF, T. (2022). Insights into the therapeutic potential of histone deacetylase inhibitor/immunotherapy combination regimens in solid tumors.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. https://doi.org/10.1007/s12094-022-02779-x
Source records
- pubmed · retrieved 2026-09-25T17:09:04.687Z
- europe-pmc · retrieved 2026-09-25T17:09:04.710Z